SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 81 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2014. The put-call ratio across all filers is 2.65 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $512,000 | -8.6% | 1,966,100 | -15.7% | 0.00% | 0.0% |
| Q1 2016 | $560,000 | -36.4% | 2,332,995 | -6.8% | 0.00% | -50.0% |
| Q4 2015 | $881,000 | -30.8% | 2,504,200 | +281.3% | 0.00% | -33.3% |
| Q1 2015 | $1,274,000 | -24.8% | 656,700 | +2.7% | 0.00% | -25.0% |
| Q4 2014 | $1,695,000 | +49.2% | 639,581 | +69.5% | 0.00% | +33.3% |
| Q3 2014 | $1,136,000 | +1.3% | 377,275 | +76.3% | 0.00% | 0.0% |
| Q4 2013 | $1,121,000 | – | 214,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |